Ascendia Pharmaceutical Solutions to Showcase Drug Delivery and Formulation Expertise at PODD 2026

Ascendia Pharmaceutical Solutions will sponsor and exhibit at Partnership Opportunities in Drug Delivery (PODD) 2026 , taking place October 29-30 at the Sheraton Boston Hotel in Boston, Massachusetts. Attendees can meet the team at booth #526B to discuss formulation development, drug delivery technologies, sterile manufacturing, and strategies for advancing pharmaceutical programs from early development through clinical and commercial manufacturing.

As a conference sponsor, Ascendia Pharmaceutical Solutions will also contribute to the technical program. Shaukat Ali, Senior Director, Scientific Affairs & Technical Marketing, will present on long-acting injectable formulations and the role of nanosuspensions in drug delivery.

Meet Ascendia Pharmaceutical Solutions at PODD 2026

Shaukat Ali, Senior Director, Scientific Affairs & Technical Marketing, and Danni Song, Associate Director, Business Development, will represent Ascendia Pharmaceutical Solutions throughout the conference. Both executives will be available to host meetings at booth #526B and discuss development priorities, formulation challenges, and manufacturing requirements across the drug development lifecycle.

These discussions provide pharmaceutical and biotechnology companies with direct access to scientific and business development leadership. Sponsors can evaluate technical approaches, identify development considerations, and discuss manufacturing strategies based on program requirements.

Ascendia Pharmaceutical Solutions supports programs through preformulation studies and formulation development, analytical method development and validation, clinical trial material manufacturing, scale-up, technology transfer, and commercial manufacturing preparation. Capabilities span multiple dosage forms and routes of administration, including oral solid dosage forms, sterile injectables, and ophthalmic products.

Technical Presentation: Long-Acting Injectables and Nanosuspensions

Shaukat Ali will present "Long-Acting Injectables: Taking a Closer Look Into Nanosuspensions" on Thursday, October 29, from 4:30 to 4:45 p.m. in the Grand Room. The presentation is part of Drug Delivery Technology Track 1B: Injectable Formulations & Technologies, Part 2.

The presentation will examine the importance of nanosuspensions in drug delivery, enabling technologies used to develop nanosuspension formulations, and considerations for nanosuspension design and aseptic manufacturing.

Nanosuspension technologies can support the development of formulations for compounds with challenging physicochemical properties. For long-acting injectable programs, formulation design must account for drug characteristics, delivery requirements, manufacturing feasibility, and the controls needed to produce sterile drug products.

Understanding these factors early can help sponsors assess formulation options, identify technical risks, and plan the development and manufacturing activities required to advance an injectable program.

Attendees can review the presentation details and session information on the PODD website and learn more about Shaukat Ali's conference profile .

Drug Delivery Development and Manufacturing Support

PODD brings together pharmaceutical and biotechnology companies, drug delivery technology providers, and potential development partners to discuss advances in drug delivery science and opportunities for collaboration.

The 2026 conference program addresses technologies designed to improve the delivery of small molecules, proteins, peptides, mRNA therapies, gene therapies, and gene-editing therapies. These approaches can introduce formulation, analytical, scale-up, and manufacturing requirements that must be addressed as programs progress.

Ascendia Pharmaceutical Solutions works with sponsors to evaluate formulation strategies and align development activities with the requirements of each drug product. Its services include preformulation, formulation development, analytical method development and validation, clinical trial material manufacturing, scale-up, technology transfer, and commercial manufacturing preparation.

Ascendia Pharmaceutical Solutions evaluates formulation requirements across a range of drug delivery technologies, including liposome drug delivery , where particle characteristics, encapsulation efficiency, stability, analytical characterization, and manufacturing scale-up can influence product performance and development decisions.

Analytical methods, stability studies, and scalable formulation strategies also help sponsors assess product quality and manufacturing readiness. Maintaining analytical rigor, stability, and scalable formulation throughout development can help identify technical challenges early to support informed decisions as programs advance toward clinical and commercial manufacturing.

Engaging scientific and manufacturing teams early can help sponsors assess technical feasibility, define development priorities, and establish a practical path toward clinical supply and subsequent manufacturing stages. At PODD 2026, meetings with Ascendia Pharmaceutical Solutions will provide an opportunity to discuss these requirements in the context of specific programs.

Pharmaceutical and biotechnology companies evaluating drug delivery technologies, developing complex formulations, or planning injectable manufacturing can meet with Ascendia Pharmaceutical Solutions during PODD 2026.

Schedule a meeting with Shaukat Ali and Danni Song at booth #526B to discuss formulation challenges, development strategy, analytical requirements, and manufacturing planning. Meetings can be arranged through the Ascendia Pharmaceutical Solutions PODD 2026 scheduling page or through the conference's dedicated partnering app.

PODD 2026 Event Details

Event: PODD 2026 - Partnership Opportunities in Drug Delivery

Dates: October 29-30, 2026

Location: Sheraton Boston Hotel, Boston, Massachusetts

Sponsor and exhibitor: Ascendia Pharmaceutical Solutions

Booth: #526B

Technical presentation: Long-Acting Injectables: Taking a Closer Look Into Nanosuspensions

Meeting scheduling: Schedule a meeting

Registration discount: Use code ASCEND10 for 10% off conference registration.

Contact Ascendia Pharmaceutical Solutions to arrange a meeting and discuss the technical and manufacturing requirements of an upcoming drug development program.